Introduction
Improvements in analytical detection methods for trace organic compounds over the past decade have allowed for the quantification of numerous contaminants, including pharmaceuticals, hormones, and personal-care products in various environmental media. One of the primary sources of these compounds is effluent from wastewater treatment plants (WWTPs) (Glassmeyer et al., 2005; Lee and Rasmussen, 2006; Miao et al., 2004) . Although the presence of therapeutic pharmaceuticals in WWTP effluent has been well established, there is limited published information available on the presence of illicit drugs in WWTP effluent. A small number of studies have reported the presence of illicit drugs in WWTP effluents at ng/ L levels, including methamphetamine, MDMA (ecstasy), tetrahydrocannabinol (THC), and cocaine and cocaine metabolites (Bones et al., 2007; Jones-Lepp et al., 2004; Zuccato et al., 2005 Zuccato et al., , 2008 . Analysis of illicit drugs in WWTP effluents has been proposed for use as a tool to estimate community-level consumption of illicit drugs and abused pharmaceuticals (Daughton, 2001; Bones et al., 2007; Zuccato et al., 2005) . There are also limited studies of the ecotoxicological impacts of chronic low-level exposures of therapeutic or illicit pharmaceuticals in aquatic systems (Fent et al., 2006; Pounds et al., 2008) , however, a limited number of ecotoxicological impacts of pharmaceuticals have been reported at environmentally relevant concentrations (Raldua et al., 2008; Schreiber and Szewzyk, 2008) . Because these compounds are biologically active, ecotoxicological and human health impacts are of potential concern.
Although the occurrence and concentration of illicit and therapeutic pharmaceuticals are documented using discrete sampling events, there are fewer data available regarding the time-weighted average concentrations of these compounds in receiving waters downstream of WWTP outfalls. Traditional water sampling approaches, such as grab and composite sampling, are shown to be effective for documenting the occurrence of pharmaceuticals, but these sampling techniques only capture information at the time of sample collection, and may miss events such as changes in the flow regime, chemical inputs and/or the influence of precipitation (MacLeod et al., 2007) . In addition, continuous on-line sampling methods may be prohibitively expensive. One device that has been developed for use in sampling trace organic compounds is the Polar Organic Chemical Integrative Sampler (POCIS). This sampling device is designed to trap polar organic compounds from water. Its ease of use and apparent resistance to biofouling make it particu-larly attractive for determining time-weighted average (TWA) concentrations of organic compounds in water . POCIS have been used previously for both qualitative and quantitative evaluation of pharmaceuticals, pesticides and hormones in surface waters (Alvarez et al., , 2007 Arditsoglou and Voutsa, 2008; Harman et al., 2008; Jones-Lepp et al., 2004; MacLeod et al., 2007; Zhang et al., 2008) .
In this study, we evaluated the occurrence and concentration of twenty pharmaceuticals (both illicit and therapeutic) and related metabolites in surface waters upstream and downstream of WWTP outfalls and in WWTP effluent in Nebraska. The treatment plants monitored serve populations ranging from 20,000 to approximately 420,000 and represent a variety of secondary treatment technologies, including trickling filter, activated sludge, trickling filters and activated sludge in parallel, and biological nutrients. The purpose of this study was (1) to evaluate in-stream TWA concentrations of pharmaceuticals in surface waters impacted by WWTP effluents and in WWTP effluent in Nebraska; (2) to determine the impact of secondary treatment type on the occurrence and concentration of pharmaceuticals in receiving waters; (3) to evaluate the use of PO-CIS as a semi-quantitative tool for assessing organic compound concentrations in surface waters; and (4) to document the presence of an illicit drug, methamphetamine, in WWTP effluents originating from rural municipalities.
Methods and materials

Sampling locations
Surface waters were sampled upstream and downstream of the WWTP discharge structure at Lincoln, NE; Grand Island, NE; and Columbus, NE. In addition, samplers were installed downstream of the Hastings, NE WWTP. Samples were also obtained from the effluent channel just prior to discharge in the Missouri River at the Omaha, NE WWTP due to the inaccessibility of the receiving water body at this location. See Table 1 for a summary of sampling locations. All samples were obtained between August and October 2006, during fall baseflow when ground water is a primary source of water to the stream sampled.
Additional information related to each WWTP including the community population, the average daily flow, and the secondary treatment technique employed at each facility is given in Table 1 .
POCIS and sampling methodology
POCIS, holders and deployment canisters were obtained from Environmental Sampling Technologies (EST, Inc., St. Joseph, MO). Each stainless steel canister was fitted with three pharmaceutical POCIS filled with Oasis HLB sorbent (Waters Corporation, Milford, MA). Each POCIS device had a surface area of 41 cm 2 and contained 200 mg of sorbent medium. At each sampling location, canisters were deployed for a 7-day exposure period. At the Grand Island site, the downstream POCIS was recovered 4 weeks after deployment, ostensibly due to vandalism. At sites where upstream and downstream samples were obtained, POCIS devices were deployed at each location simultaneously. All sites were sampled between August and November 2006, when baseflow is a primary source of water in the receiving water bodies. The sampling period was also outside of the required seasonal disinfection period, so no disinfection processes were ongoing at the time of sampling.
Solvents and internal standards
Reference materials, metabolites and labeled standards, including 13 C 3 -caffeine and d 9 -methamphetamine, were obtained from Sigma-Aldrich (St. Louis, MO). Phenyl-13 C 8 -sulfamethazine was purchased from Cambridge Isotopes (Andover, MA). Solvents used in sample preparation were high-purity grade (OPTIMA, Fisher Scientific, St. Louis, MO).
Extraction methodology
Handling and elution of POCIS followed procedures described previously Jones-Lepp et al., 2004) . After the 7-day exposure, each individual POCIS device was removed from its deployment canister, briefly rinsed with water if needed to remove debris and opened. The contents of the POCIS were transferred using approximately 20 mL of high-purity methanol directly into silane-treated vials. Vials containing the methanol and sorbent were held at −20 °C until they could be processed for analysis.
Target compounds were eluted by passing 50 mL of high-purity methanol through silane-treated glass gravity flow chromatography columns into 120 mL evaporation tubes (RapidVAP, Labconco, Kansas City, MO). Approximately 1 ng of d 9 -methamphetamine, 13 C 3 -caffeine, and phenyl-13 C 8 -sulfamethazine internal standards were added to the eluate and used for quantification. Extracts were evaporated under nitrogen to approximately 1 mL, and quantitatively transferred to autosampler vials for analysis by liquid chromatographytandem mass spectrometry (LC/MS/MS). Standards and spiking solutions were prepared from stock solutions (5 μg/μL) in methanol. Calibration solutions (2, 5, 12.5, 25 and 50 pg/μL) were prepared in 50:50 methanol and water. All standards and extracts were stored in amber vials at −20 °C.
Liquid chromatography-tandem mass spectrometry
POCIS extracts were analyzed for twenty pharmaceuticals and metabolites, as listed in Table 2 . Standards and extracts were analyzed on a Quattro Micro triple quadrupole with a Waters 2695 high pressure liquid chromatograph (HPLC) and autosampler. Electrospray ionization in positive ion mode was used for the detection of target compounds by multiple reaction monitoring (MRM) with argon collision gas. A Thermo (Bellefonte, PA) Betabasic-18 column (250 × 2.1 mm, 5 μm, 50 °C) was used for separation at a flow rate of 0.2 ml/min with a gradient of methanol with 0.1% formic acid in water. Mass spectrometer operational parameters were optimized by infusing each compound separately ( Table 2 ). The source conditions were: capillary 2.5 kV, extractor 2 V, RF lens 0.8 V, source temp 90 °C, desolvation temp 400 °C, cone gas flow at 30 L/h, and desolvation gas flow at 700 L/h. Compound retention times, ionization modes and MRM transitions are listed in Table 2 . A five-point internal standard calibration curve was used for quantification of each analyte. Methamphetamine-d 3 was used as the internal standard for methamphetamine and d(extro)-amphetamine, phenyl-13 C 8 -sulfamethazine was used for sulfa antibiotics and 13 C 3 -caffeine was used as the internal standard for all other target compounds. Based on the variability of the lowest standard (2 pg/μL), the estimated detection limits for most compounds are less than 1 pg/μL, corresponding to 1 ng recovered from the PO-CIS. Recovery of target compounds was checked by analysis of fortified blanks spiked with known amounts of each compound and averaged 123 ± 30%. Two laboratory reagent blanks were processed with the POCIS samples, with all compounds below instrument detection limits listed in Table 1 .
Calculation of POCIS uptake rakes
In order to use POCIS as a quantitative tool, an uptake rate must be determined for each compound of interest. Compound uptake by POCIS is controlled by the aqueous boundary layer , therefore, the sampling rate, R s , (L/d) is:
where D w is the aqueous diffusion coefficient of the compound, L w is the thickness of the stagnant film layer, and A is the surface area of the sampler. Based on 
where C w and C s are the concentrations of the compound in the aqueous and sorbent phases, respectively, M s is the mass of sorbent, and t is the exposure time.
One limitation of POCIS is the need to determine the uptake rates for the compounds of interest for qualitative analysis. To date, uptake rates have been calculated for a limited number of hormones, pharmaceuticals and personal-care products Jones-Lepp et al., 2004; MacLeod et al., 2007; Togola and Budzinski, 2007) . In this study, we calculated theoretical uptake rates for the pharmaceuticals of interest, and used these values in Equation (2) to determine aqueous concentrations. Based on the uptake rate data collected under turbulent conditions reported by MacLeod et al. (2007) for POCIS containing the Oasis HLB sorbent, and using D w values estimated at 25 °C using the HaydukLaudie model (Lyman et al., 1982) , an average L w value of 0.025 ± 0.002 cm was determined. Based on this value and calculated D w values, R s values for the compounds of interest were calculated for the twenty pharmaceutical compounds measured in this study. (Togola and Budzinski, 2007) . Variability within a factor of 2-3 is consistent with variability in contaminant concentrations observed in the field based on continuous monitoring over an extended period (Togola and Budzinski, 2007) .
Results and discussion
Estimated aqueous concentrations of contaminants recovered from POCIS at each sampling location are presented in Table  4 . Of the twenty pharmaceutical compounds and metabolites, 17 were detected at no less than one of the sampling sites. dAmphetamine, virginiamycin and sulfathiazole were not detected in any of the POCIS residues. At all sampling locations, there were more occurrences of prescription and non-prescription drugs and human antibiotics than veterinary antibiotics, which were expected based on the municipal source of the discharge. For most of the pharmaceuticals investigated, the recovered mass and estimated concentration of a given compound in the downstream sample was significantly higher than in the sample upstream from the WWTP discharge structure. This result indicates that WWTP effluent is a significant source of pharmaceutical loading to the receiving waters, a finding in agreement with other studies which have also demonstrated WWTP effluent to be a significant source of pharmaceutical loading to the environment (Batt et al., 2006; Kim et al., 2007; Lee and Rasmussen, 2006; Roberts and Thomas, 2006) . The pharmaceuticals that were detected in all sampling locations (upstream of discharge structure, downstream of discharge structure, and effluent) were caffeine; 1,7-dimethylxanthine, a caffeine metabolite; cotinine, a nicotine metabolite; DEET, and diphenhydramine. The estimated concentration of these compounds ranged from 1.9 ng/L to 30.3 ng/L in the It should be noted that caffeine was detected upstream of the Lincoln, NE WWTP at a concentration of 216 ng/L, which is significantly higher than the downstream concentration observed at this site. The presence of these compounds in the upstream samples indicates that they may be persistent in the environment or that surface run-off is a significant source of these contaminants. Acetaminophen, azithromycin and carbamazepine were also detected at a large number of the sampling locations. Acetaminophen was detected at all sampling locations with the exception of the upstream sample at Grand Island, NE; the downstream sample at Columbus, NE; and the effluent sample at Omaha, NE. Azithromycin was not detected in any of the upstream samples, but was detected in all downstream and effluent samples and carbamazepine was detected in all sampling locations with the exception of the upstream samples at Columbus, NE and Lincoln, NE. The presence of azithromycin and carbamazepine in all of the effluent and downstream samples, but not in the upstream samples, suggests that surface run-off is not a significant source of these compounds or that they may be more readily degraded in surface waters or preferentially sorbed to sediments. The WWTPs sampled represent a variety of secondary treatment types, including activated sludge, trickling filter, trickling filter and activated sludge in parallel, and biological nutrients. Although concentrations of pharmaceuticals in the raw sewage at each location were not monitored, it is expected that they would be similar as municipal sources are the primary source of wastewater to each of these WWTPs. Therefore, evaluation of the in-stream pharmaceutical concentrations downstream of the discharge structure at each WWTP should provide some qualitative information about the relative performance of each treatment technology for removal of pharmaceuticals in wastewater. As seen in Figure 1 , for the 13 compounds measured in common at each of the four WWTPs where in-stream measurements were taken, the activated sludge treatment results in the lowest pharmaceutical concentration for all compounds with the exception of cotinine. Pharmaceutical concentrations in the streams impacted by effluents from WWTPs with trickling filters or trickling filters in parallel with activated sludge resulted in the highest observed in-stream pharmaceutical concentrations. This result is in agreement with previous studies that have determined that trickling filter secondary treatment systems yield larger organic wastewater contaminant concentrations when compared with activated sludge processes (Carbella et al., 2004; Lee and Rasmussen, 2006) .
Trace levels of the illicit drug methamphetamine were detected at most sampling locations. The other illicit pharmaceutical and methamphetamine metabolite, d-amphetamine, was not detected in any of the POCIS. These data represent only the second report of methamphetamine detected in WWTP effluent and in streams impacted by WWTP effluent. Previously, Jones-Lepp et al. (2004) reported estimated methamphetamine concentrations of 1.3 ng/L and 0.8 ng/L from POCIS in WWTP effluent and in-stream samples, respectively. These samples were obtained at a WWTP located in Las Vegas, Nevada, a large metropolitan area. In this study, estimated methamphetamine concentrations in about half of the samples were comparable to those reported from Las Vegas, while estimated levels in the WWTP effluent and downstream samples from three sites were 350 ng/L (effluent) and 2.3-62.6 ng/L (downstream). The effluent sample was obtained from Omaha, NE, which has a population of 491,000, while the downstream samples were obtained from municipalities with populations ranging from 20,000 to 240,000. The differences between data obtained from these locations and previously reported results may reflect differences in drug use, wastewater treatment practices and timing of sample collection. The prevalence of trace levels of methamphetamine, caffeine, 1,7-dimethylzanthine, and several other pharmaceuticals may also suggest the presence of positive interferences for these compounds. Although LC-tandem mass spectrometry is among the most sensitive and selective methods available for the detection of polar organic compounds, it is not immune from false positives (Pozo et al., 2006) . The use of isotope-labeled analogues as internal standards for selected target analytes (caffeine, methamphetamine, and sulfamethanzine) increases the selectivity of the analysis for these compounds.
The use of passive samplers which can develop information on time-weighted average concentrations of contaminants in water samples can be used effectively for semi-quantitative analysis of polar compounds such as pesticides, pharmaceuticals, and hormones. As stated previously, the limitation of POCISs is the need to perform laboratory calibration experiments to determine contaminant uptake rates. As demonstrated by Togola and Budinski (2007) , the magnitude of the uptake rate can be influenced by the environmental conditions of the water matrix, including salinity and temperature. Based on the results from this study, the theoretical uptake rates calculated based on the calculated stagnant film layer and water diffusion coefficient are reasonable when compared to uptake rates calculated from laboratory calibration experiments. The use of calculated uptake rates to predict aqueous concentrations makes the POCIS more attractive for use in experimental studies when quantitative or semi-quantitative data are required and uptake rates determined from laboratory calibration are not available. Further research is needed to fully characterize how different environmental variables influence contaminant uptake rates for POCIS to fully assess whether calculated uptake rates can be used to quantify POCIS results.
Conclusions
POCIS were deployed in receiving waters upstream and downstream of wastewater treatment plant discharge structures and in one wastewater effluent channel. Calculated uptake rates were reasonable when compared with previously published uptake rates determined by laboratory experiments, and were used to determine estimated aqueous concentrations of nineteen pharmaceutical compounds and metabolites. Concentrations upstream and downstream of the WWTP discharge structure indicate that wastewater is a significant contributor to pharmaceutical loadings in receiving waters. Trace concentrations of methamphetamine, an illicit pharmaceutical, were present in all but one sampling location at higher concentrations than have been previously reported for this compound.
